Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Candidiasis, which includes both superficial infections and invasive disease, is the most common cause of fungal infection worldwide.Candida bloodstream infections (BSI) cause significant mortality and elicit a major threat to intensive care unit (ICU) patients [1].The annual global burden of Candida spp.BSIs is about 400,000 cases, with most cases reported from the developed world.Although Candida albicans remains the most frequently isolated Candida species in the clinical setting, in some countries, a marked shift towards species of Candida that have increased resistance to azoles such as fluconazole (FLU), the standard antifungal drug of choice in many countries, and to the recently introduced antifungals known as echinocandins, is reported.Several species of non-albicans Candida, such as C. tropicalis, C. glabrata, and C. parapsilosis, are well-recognized pathogens in BSIs in different geographic locations.More recently, Candida auris, a multidrug-resistant (MDR) yeast that exhibits resistance to FLU and markedly variable susceptibility to other azoles, amphotericin B (AMB), and echinocandins, has globally emerged as a nosocomial pathogen (Fig 1) [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20].Alarmingly, in a span of only 7 years, this yeast, which is difficult to treat and displays clonal inter-and intra-hospital transmission, has become widespread across several countries, causing a broad range of healthcare-associated invasive infections [4,5,10,12,21,22].
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Resistance to all three classes of antifungals is reported most commonly in India in South Asia (3%), whereas this is much less common in other regions of the world.122–124”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [123]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Resistance to the echinocandins (up to 7%) and amphotericin B (up to 35%) vary greatly between geographic regions.122–124”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [123]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is noted for its potential multidrug antifungal resistance, but the data demonstrate resistance to fluconazole, seen in 70% to 90% of isolates, and they are non-susceptible to quaternary-ammonium disinfectants, allowing this pathogen to persist on healthcare related surfaces and cause outbreaks.122,123”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [123]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“the emerging fungal threat C. auris is often MDR.17 , 27 , 36 , 37”
From Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans (2020) · cites this paper as [27]
The cited source says what the claim attributes to it.
In the citing paper
“Most alarmingly, some isolates have been reported to show elevated resistance to all three major antifungal classes, leaving no treatment options for such infections (4).”
From Genetic Analysis of Candida auris Implicates Hsp90 in Morphogenesis and Azole Tolerance and Cdr1 in Azole Resistance (2019) · cites this paper as [4]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J.-L. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,618
Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662
Self-citationSatoh, K., Makimura, K., Hasumi, Y., Nishiyama, Y., Uchida, K., & Yamaguchi, H. (2009) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00083.x · Cited by 1,381
First hospital outbreak of the globally emerging Candida auris in a European hospital
Schelenz, S., Hagen, F., Rhodes, J. L., Abdolrasouli, A., Chowdhary, A., Hall, A., Ryan, L., Shackleton, J., Trimlett, R., Meis, J. F., et al. (2016) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-016-0132-5 · Cited by 768
Self-citationKathuria, S., Singh, P. K., Sharma, C., Prakash, A., Masih, A., Kumar, A., Meis, J. F., & Chowdhary, A. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00367-15 · Cited by 532
Self-citationFirst Three Reported Cases of Nosocomial Fungemia Caused by Candida auris
Lee, W. G., Shin, J. H., Uh, Y., Kang, M. G., Kim, S. H., Park, K. H., & Jang, H.-C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00319-11 · Cited by 523
Calvo, B., Melo, A. S. A., Perozo-Mena, A., Hernandez, M., Francisco, E. C., Hagen, F., Meis, J. F., & Colombo, A. L. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.07.008 · Cited by 448
Self-citationBiofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris
Sherry, L., Ramage, G., Kean, R., Borman, A., Johnson, E. M., Richardson, M. D., & Rautemaa-Richardson, R. (2017) · Emerging Infectious Diseases · doi:10.3201/eid2302.161320 · Cited by 420
New Clonal Strain of Candida auris, Delhi, India
Chowdhary, A., Sharma, C., Duggal, S., Agarwal, K., Prakash, A., Singh, P. K., Jain, S., Kathuria, S., Randhawa, H. S., Hagen, F., et al. (2013) · Emerging Infectious Diseases · doi:10.3201/eid1910.130393 · Cited by 418
Self-citationLarkin, E., Hager, C., Chandra, J., Mukherjee, P. K., Retuerto, M., Salem, I., Long, L., Isham, N., Kovanda, L., Borroto-Esoda, K., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02396-16 · Cited by 395
Cited by
Items 101–200 of 783
Keighley, C., Garnham, K., Harch, S. A. J., Robertson, M., Chaw, K., Teng, J. C., & Chen, S. C.-A. (2021) · Current Fungal Infection Reports · doi:10.1007/s12281-021-00420-y · Cited by 87
Candida auris on Apples: Diversity and Clinical Significance
Yadav, A., Jain, K., Wang, Y., Pawar, K., Kaur, H., Sharma, K. K., Tripathy, V., Singh, A., Xu, J., & Chowdhary, A. (2022) · mBio · doi:10.1128/mbio.00518-22 · Cited by 86
Self-citationBing, J., Hu, T., Zheng, Q., Muñoz, J. F., Cuomo, C. A., & Huang, G. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01466-20 · Cited by 86
“It has been proposed that the widespread use of antifungal drugs may play a critical role in the emergence of this fungus (4).”
BackgroundMathur, P., Hasan, F., Singh, P. K., Malhotra, R., Walia, K., & Chowdhary, A. (2018) · Mycoses · doi:10.1111/myc.12790 · Cited by 86
Self-citationThe first cases of Candida auris candidaemia in Oman
Mohsin, J., Hagen, F., Al‐Balushi, Z. A. M., de Hoog, G. S., Chowdhary, A., Meis, J. F., & Al‐Hatmi, A. M. S. (2017) · Mycoses · doi:10.1111/myc.12647 · Cited by 83
Self-citationCandida auris: Epidemiology and Antifungal Strategy
Eix, E. F., & Nett, J. E. (2025) · Annual Review of Medicine · doi:10.1146/annurev-med-061523-021233 · Cited by 74
Candida auris outbreak: Mortality, interventions and cost of sustaining control
Taori, S. K., Khonyongwa, K., Hayden, I., Athukorala, G. D. A., Letters, A., Fife, A., Desai, N., & Borman, A. M. (2019) · Journal of Infection · doi:10.1016/j.jinf.2019.09.007 · Cited by 86
Candida auris: A Quick Review on Identification, Current Treatments, and Challenges
Černáková, L., Roudbary, M., Brás, S., Tafaj, S., & Rodrigues, C. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094470 · Cited by 91
Burrack, L. S., Todd, R. T., Soisangwan, N., Wiederhold, N. P., & Selmecki, A. (2022) · mBio · doi:10.1128/mbio.00842-22 · Cited by 82
What Do We Know about Candida auris? State of the Art, Knowledge Gaps, and Future Directions
García-Bustos, V., Cabañero-Navalón, M. D., Ruiz‐Saurí, A., Gaitán, A. C. R., Salavert, M., Tormo‐Más, M. Á., & Pemán, J. (2021) · Microorganisms · doi:10.3390/microorganisms9102177 · Cited by 89
Antifungal Drugs TDM: Trends and Update
Kably, B., Launay, M., Derobertmasure, A., Lefeuvre, S., Dannaoui, E., & Billaud, E. M. (2022) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000952 · Cited by 81
Wiederhold, N. P., Lockhart, S. R., Najvar, L. K., Berkow, E. L., Jaramillo, R., Olivo, M., Garvey, E. P., Yates, C. M., Schotzinger, R. J., Catano, G., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02233-18 · Cited by 79
Antifungal Susceptibility Testing: A Primer for Clinicians
Wiederhold, N. P. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab444 · Cited by 88
Angioinvasive fungal infections impacting the skin
Shields, B. E., Rosenbach, M. A., Brown‐Joel, Z. O., Berger, A. P., Ford, B. A., & Wanat, K. A. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.04.059 · Cited by 86
Ahmad, S., Khan, Z., Al‐Sweih, N., Alfouzan, W., & Joseph, L. (2020) · Mycoses · doi:10.1111/myc.13022 · Cited by 79
Molecular Epidemiology of Candida Auris Outbreak in a Major Secondary-Care Hospital in Kuwait
Alfouzan, W., Ahmad, S., Dhar, R., Asadzadeh, M., Almerdasi, N., Abdo, N. M., Joseph, L., de Groot, T., Alali, W. Q., Khan, Z., et al. (2020) · Journal of Fungi · doi:10.3390/jof6040307 · Cited by 74
Self-citationSaris, K., Meis, J. F., & Voss, A. (2018) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000469 · Cited by 76
Self-citationCandida auris: a worrisome, globally emerging pathogen
Navalkele, B. D., Revankar, S., & Chandrasekar, P. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1364992 · Cited by 74
Antimicrobial Coatings: Reviewing Options for Healthcare Applications
Jose, A., Gizdavic‐Nikolaidis, M. R., & Swift, S. (2023) · Applied Microbiology · doi:10.3390/applmicrobiol3010012 · Cited by 80
Hoenigl, M., Gangneux, J., Segal, E., Alanio, A., Chakrabarti, A., Chen, S. C. ‐., Govender, N., Hagen, F., Klimko, N., Meis, J. F., et al. (2018) · Mycoses · doi:10.1111/myc.12836 · Cited by 72
Self-citationCarolus, H., Sofras, D., Boccarella, G., Sephton-Clark, P., Biriukov, V., Cauldron, N. C., Lobo Romero, C., Vergauwen, R., Yazdani, S., Pierson, S., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01854-z · Cited by 72
Self-citationAlatoom, A., Sartawi, M., Lawlor, K., AbdelWareth, L., Thomsen, J., Nusair, A., & Mirza, I. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.02.005 · Cited by 70
Wiederhold, N. P., Najvar, L. K., Shaw, K. J., Jaramillo, R., Patterson, H., Olivo, M., Catano, G., & Patterson, T. F. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01120-19 · Cited by 71
Arendrup, M. C., Jørgensen, K. M., Hare, R. K., & Chowdhary, A. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02136-19 · Cited by 70
Self-citationCandidemia in children: Epidemiology, prevention and management
Mantadakis, E., Pana, Z. D., & Zaoutis, T. E. (2018) · Mycoses · doi:10.1111/myc.12792 · Cited by 77
First reported case of multidrug-resistant Candida auris in Canada
Schwartz, I., & Hammond, G. (2017) · Canada Communicable Disease Report · doi:10.14745/ccdr.v43i78a02 · Cited by 67
Eugenol: A novel therapeutic agent for the inhibition of Candida species infection
Didehdar, M., Chegini, Z., & Shariati, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.872127 · Cited by 85
Pathirana, R. U., Friedman, J., Norris, H. L., Salvatori, O., McCall, A. D., Kay, J., & Edgerton, M. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01872-17 · Cited by 70
Iguchi, S., Itakura, Y., Yoshida, A., Kamada, K., Mizushima, R., Arai, Y., Uzawa, Y., & Kikuchi, K. (2019) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2019.05.034 · Cited by 69
Update on the Pathogenesis, Virulence, and Treatment of Candida auris
Watkins, R. R., Gowen, R., Lionakis, M., & Ghannoum, M. (2022) · Pathogens and Immunity · doi:10.20411/pai.v7i2.535 · Cited by 68
Pharmaceutical Approaches on Antimicrobial Resistance: Prospects and Challenges
Nainu, F., Permana, A. D., Djide, N. J. N., Anjani, Q. K., Utami, R. N., Rumata, N. R., Zhang, J., Emran, T. B., & Simal‐Gándara, J. (2021) · Antibiotics · doi:10.3390/antibiotics10080981 · Cited by 79
de Oliveira, H. C., Monteiro, M. C., Rossi, S. A., Pemán, J., Ruiz-Gaitán, A., Mendes-Giannini, M. J. S., Mellado, E., & Zaragoza, O. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00083 · Cited by 70
Hou, X., Lee, A., Jiménez-Ortigosa, C., Kordalewska, M., Perlin, D. S., & Zhao, Y. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01811-18 · Cited by 66
“discharge of a patient in Japan (1) and quickly spread around the globe, with reports from five continents (2, 3).”
BackgroundVatanshenassan, M., Boekhout, T., Meis, J. F., Berman, J., Chowdhary, A., Ben-Ami, R., Sparbier, K., & Kostrzewa, M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00020 · Cited by 66
Self-citationMultidrug-resistant Candida auris : an epidemiological review
Chakrabarti, A., & Singh, S. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1750368 · Cited by 66
Garcia-Bustos, V., Ruiz-Saurí, A., Ruiz-Gaitán, A., Sigona-Giangreco, I. A., Cabañero-Navalon, M. D., Sabalza-Baztán, O., Salavert-Lletí, M., Tormo, M. Á., & Pemán, J. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00013-21 · Cited by 66
“high resistance to antifungal agents and common disinfectants (5, 6), its unprece-”
BackgroundAllert, S., Schulz, D., Kämmer, P., Großmann, P., Wolf, T., Schäuble, S., Panagiotou, G., Brunke, S., & Hube, B. (2022) · Virulence · doi:10.1080/21505594.2022.2026037 · Cited by 66
Synergistic and antagonistic drug interactions in the treatment of systemic fungal infections
Wambaugh, M. A., Denham, S. T., Ayala, M., Brammer, B., Stonhill, M. A., & Brown, J. C. (2020) · eLife · doi:10.7554/elife.54160 · Cited by 65
“neoformans, as well as clinical isolates of the increasingly problematic and multi-drug resistant species Candida auris (Chowdhary et al., 2017).”
BackgroundThe CRISPR toolbox in medical mycology: State of the art and perspectives
Morio, F., Lombardi, L., & Butler, G. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008201 · Cited by 68
Hu, S., Zhu, F., Jiang, W., Wang, Y., Quan, Y., Zhang, G., Gu, F., & Yang, Y. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.658329 · Cited by 64
Brandão, J. C., Gangneux, J., Arıkan-Akdağlı, S., Barac, A. M., Bostănaru, A.-C., Brito, S., Bull, C. M., Çerikçioğlu, N., Chapman, B., Efstratiou, M. A., et al. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.146598 · Cited by 71
Gómez-Gaviria, M., Martínez-Álvarez, J. A., Chávez-Santiago, J. O., & Mora-Montes, H. M. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s402754 · Cited by 69
Bidaud, A. L., Botterel, F., Chowdhary, A., & Dannaoui, E. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01393-19 · Cited by 62
Self-citationA common vesicle proteome drives fungal biofilm development
Zarnowski, R., Sanchez, H., Jaromin, A., Zarnowska, U. J., Nett, J. E., Mitchell, A. P., & Andes, D. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211424119 · Cited by 63
Mortality Trends in Risk Conditions and Invasive Mycotic Disease in the United States, 1999–2018
Rayens, E., Norris, K. A., & Cordero, J. F. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab336 · Cited by 63
Khan, Z., Ahmad, S., Benwan, K., Purohit, P., Al-Obaid, I., Bafna, R., Emara, M., Mokaddas, E., Abdullah, A. A., Al-Obaid, K., et al. (2018) · Infection · doi:10.1007/s15010-018-1164-y · Cited by 63
Candida auris Sternal Osteomyelitis in a Man from Kenya Visiting Australia, 2015
Heath, C. H., Dyer, J. R., Pang, S., Coombs, G. W., & Gardam, D. J. (2019) · Emerging Infectious Diseases · doi:10.3201/eid2501.181321 · Cited by 59
What’s new on emerging resistant Candida species
Cortegiani, A., Misseri, G., & Chowdhary, A. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5363-x · Cited by 67
Self-citationGarcia-Bustos, V., Salavert, M., Ruiz-Gaitán, A. C., Cabañero-Navalon, M. D., Sigona-Giangreco, I. A., & Pemán, J. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.02.001 · Cited by 61
Lockhart, S. R., Jackson, B. R., Vallabhaneni, S., Ostrosky-Zeichner, L., Pappas, P. G., & Chiller, T. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01355-17 · Cited by 61
Ong, C. W., Chen, S. C. ‐., Clark, J. E., Halliday, C. L., Kidd, S. E., Marriott, D. J., Marshall, C. L., Morris, A. J., Morrissey, C. O., Roy, R., et al. (2019) · Internal Medicine Journal · doi:10.1111/imj.14612 · Cited by 58
Clade II Candida auris possess genomic structural variations related to an ancestral strain
Sekizuka, T., Iguchi, S., Umeyama, T., Inamine, Y., Makimura, K., Kuroda, M., Miyazaki, Y., & Kikuchi, K. (2019) · PLOS ONE · doi:10.1371/journal.pone.0223433 · Cited by 59
Shivarathri, R., Jenull, S., Stoiber, A., Chauhan, M., Mazumdar, R., Singh, A., Nogueira, F., Kuchler, K., Chowdhary, A., & Chauhan, N. (2020) · mSphere · doi:10.1128/msphere.00973-20 · Cited by 59
Self-citationSharma, C., & Kadosh, D. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011190 · Cited by 63
Self-citationBougnoux, M., Brun, S., & Zahar, J. (2018) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-018-0338-9 · Cited by 64
Arastehfar, A. A., Fang, W., Pan, W., Lackner, M., Liao, W., Badiee, P., Zomorodian, K., Badali, H., Hagen, F., Lass‐Flörl, C., et al. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.09.007 · Cited by 66
Engineering the Bioactivity of Flame-Made Ceria and Ceria/Bioglass Hybrid Nanoparticles
Matter, M. T., Furer, L. A., Starsich, F. H. L., Fortunato, G., Pratsinis, S. E., & Herrmann, I. K. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b18778 · Cited by 63
Investigating Antifungal Susceptibility in Candida Species With MALDI-TOF MS-Based Assays
Delavy, M., Santos, A. R. D., Heiman, C. M., & Coste, A. T. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00019 · Cited by 66
Shivarathri, R., Tscherner, M., Zwolanek, F., Singh, N. K., Chauhan, N., & Kuchler, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-45817-5 · Cited by 58
Vila, T., Montelongo-Jauregui, D., Ahmed, H., Puthran, T., Sultan, A. S., & Jabra-Rizk, M. A. (2020) · mSphere · doi:10.1128/msphere.00760-20 · Cited by 58
“tween yeast and hyphal forms (5, 17), and the lack of filamentation may explain the”
BackgroundCorzo-León, D., Peacock, M., Rodríguez‐Zulueta, P., Salazar-Tamayo, G., & MacCallum, D. M. (2020) · Medical Mycology · doi:10.1093/mmy/myaa098 · Cited by 64
Martins‐Santana, L., Rezende, C. P., Rossi, A., Martinez-Rossi, N. M., & Almeida, F. B. D. R. (2023) · Pathogens · doi:10.3390/pathogens12020293 · Cited by 66
Tian, S., Rong, C., Nian, H., Li, F., Chu, Y., Cheng, S., & Shang, H. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0131-0 · Cited by 58
Multidrug transporters of Candida species in clinical azole resistance
Prasad, R., Nair, R., & Banerjee, A. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103252 · Cited by 57
Wall, G., Herrera, N., & Lopez-Ribot, J. L. (2019) · Journal of Fungi · doi:10.3390/jof5040092 · Cited by 58
Expert recommendations for prevention and management of Candida auris transmission
Aldejohann, A. M., Wiese‐Posselt, M., Gastmeier, P., & Kurzai, O. (2022) · Mycoses · doi:10.1111/myc.13445 · Cited by 65
Ongoing Challenges with Healthcare-Associated Candida auris Outbreaks in Oman
Al Maani, A., Paul, H., Al-Rashdi, A., Al Wahaibi, A., Al-Jardani, A., Al Abri, A. M. A., AlBalushi, M. A. H., Al Abri, S., Al Reesi, M., Al Maqbali, A., et al. (2019) · Journal of Fungi · doi:10.3390/jof5040101 · Cited by 57
Self-citationEldesouky, H. E., Salama, E. A., Lanman, N. A., Hazbun, T. R., & Seleem, M. N. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00684-20 · Cited by 56
Asadzadeh, M., Mokaddas, E., Ahmad, S., Abdullah, A. A., de Groot, T., Meis, J. F., & Shetty, S. A. (2022) · Mycoses · doi:10.1111/myc.13419 · Cited by 55
Self-citationAugmenting Azoles with Drug Synergy to Expand the Antifungal Toolbox
Kane, A., & Carter, D. A. (2022) · Pharmaceuticals · doi:10.3390/ph15040482 · Cited by 58
Abid, F. B., Salah, H., Sundararaju, S., Dalil, L., Abdelwahab, A. H., Salameh, S., Ibrahim, E. B., Almaslmani, M. A., Tang, P., Pérez‐López, A., et al. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.04.025 · Cited by 59
The Emerging Threat of Antifungal Resistance in Transplant Infectious Diseases
Schwartz, I. S., & Patterson, T. F. (2018) · Current Infectious Disease Reports · doi:10.1007/s11908-018-0608-y · Cited by 57
Antifungal Activity of a Medical-Grade Honey Formulation against Candida auris
de Groot, T., Janssen, T., Faro, D., Cremers, N. A. J., Chowdhary, A., & Meis, J. F. G. M. (2021) · Journal of Fungi · doi:10.3390/jof7010050 · Cited by 58
Self-citationDong, P., Zong, C., Dagher, Z., Hui, J., Li, J., Zhan, Y., Zhang, M., Mansour, M. K., & Cheng, J. (2021) · Science Advances · doi:10.1126/sciadv.abd5230 · Cited by 60
Arendrup, M. C., Chowdhary, A., Astvad, K. M. T., & Jørgensen, K. M. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01225-18 · Cited by 53
Self-citationMayr, E.-M., Ramírez-Zavala, B., Krüger, I., & Morschhäuser, J. (2020) · mSphere · doi:10.1128/msphere.00279-20 · Cited by 55
Khunweeraphong, N., & Kuchler, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094806 · Cited by 53
Jones, C. R., Neill, C., Borman, A. M., Budd, E. L., Cummins, M. N., Fry, C., Guy, R. L., Jeffery, K. J., Johnson, E. M., Manuel, R. J., et al. (2024) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001820 · Cited by 61
The emerging pathogen Candida auris: A focus on the Middle-Eastern countries
Alfouzan, W., Dhar, R., Albarrag, A., & Al-Abdely, H. (2019) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2019.03.009 · Cited by 52
Colistin interacts synergistically with echinocandins against Candida auris
Bidaud, A.-L., Djènontin, E., Botterel, F., Chowdhary, A., & Dannaoui, É. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105901 · Cited by 56
Self-citationBiofilm: The invisible culprit in catheter-induced candidemia
Wijaya, M., Halleyantoro, R., & Kalumpiu, J. F. (2023) · AIMS Microbiology · doi:10.3934/microbiol.2023025 · Cited by 59
Babler, K. M., Sharkey, M. E., Arenas, S. P., Amirali, A., Beaver, C. C., Comerford, S. T., Goodman, K. W., Grills, G. S., Holung, M., Kobetz, E. N., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.165459 · Cited by 54
Al-Rashdi, A., Al-Maani, A. S., Wahaibi, A. S. A., Alqayoudhi, A., Al‐Jardani, A., & Al-Abri, S. (2021) · Journal of Fungi · doi:10.3390/jof7010031 · Cited by 58
Wiederhold, N. P., Najvar, L. K., Olivo, M., Morris, K. N., Patterson, H. P., Catano, G., & Patterson, T. F. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02694-20 · Cited by 53
The Novel Arylamidine T-2307 Demonstrates In Vitro and In Vivo Activity against Candida auris
Wiederhold, N. P., Najvar, L. K., Jaramillo, R., Olivo, M., Patterson, H., Connell, A., Fukuda, Y., Mitsuyama, J., Catano, G., & Patterson, T. F. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02198-19 · Cited by 50
“auris isolates are often resistant to antifungals, including fluconazole and other azoles (1, 3).”
BackgroundDon't Forget the Fungi When Considering Global Catastrophic Biorisks
Casadevall, A. (2017) · Health Security · doi:10.1089/hs.2017.0048 · Cited by 50
Nanotechnological strategies for systemic microbial infections treatment: A review
Ramos, M. A. D. S., dos Santos, K. C., da Silva, P. B., de Toledo, L. G., Marena, G. D., Rodero, C. F., de Camargo, B. A. F., Fortunato, G. C., Bauab, T. M., & Chorilli, M. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119780 · Cited by 52
Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?
Soulountsi, V., Schizodimos, T., & Kotoulas, S. (2021) · Infection · doi:10.1007/s15010-021-01640-7 · Cited by 59
Role of Antifungal Combinations in Difficult to Treat Candida Infections
Vitale, R. G. (2021) · Journal of Fungi · doi:10.3390/jof7090731 · Cited by 52
Arıkan-Akdağlı, S., Ghannoum, M. A., & Meis, J. F. G. M. (2018) · Journal of Fungi · doi:10.3390/jof4040129 · Cited by 54
Self-citationCandida auris: A Mini Review on Epidemiology in Healthcare Facilities in Asia
Thatchanamoorthy, N., Rukumani, D. V., Samudi, C., & Tay, S. T. (2022) · Journal of Fungi · doi:10.3390/jof8111126 · Cited by 54
Mohsin, J., Weerakoon, S., Ahmed, S., Puts, Y., Al Balushi, Z., Meis, J. F., & Al-Hatmi, A. M. S. (2020) · Antibiotics · doi:10.3390/antibiotics9100638 · Cited by 43
Self-citationRare fungal infectious agents: a lurking enemy
Skiada, A., Pavleas, I., & Drogari‐Apiranthitou, M. (2017) · F1000Research · doi:10.12688/f1000research.11124.1 · Cited by 52
Tian, S., Bing, J., Chu, Y., Chen, J., Cheng, S., Wang, Q., Zhang, J., Ma, X., Zhou, B., Liu, L., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1934557 · Cited by 47
Arastehfar, A., Fang, W., Daneshnia, F., Al-Hatmi, A. M., Liao, W., Pan, W., Khan, Z., Ahmad, S., Rosam, K., Lackner, M., et al. (2019) · Future Microbiology · doi:10.2217/fmb-2018-0227 · Cited by 41
Semreen, M. H., Soliman, S. S. M., Saeed, B. Q., Alqarihi, A., Uppuluri, P., & Ibrahim, A. S. (2019) · Molecules · doi:10.3390/molecules24030399 · Cited by 47
Dal Mas, C., Rossato, L., Shimizu, T., Oliveira, E. B., da Silva Junior, P. I., Meis, J. F., Colombo, A. L., & Hayashi, M. A. F. (2019) · Biomolecules · doi:10.3390/biom9060205 · Cited by 46
Self-citationOne Health aspects & priority roadmap for fungal diseases: A mini-review
Banerjee, S., Denning, D. W., & Chakrabarti, A. (2021) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_768_21 · Cited by 55
Striking Back against Fungal Infections: The Utilization of Nanosystems for Antifungal Strategies
Du, W., Gao, Y., Liu, L., Sai, S., & Ding, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810104 · Cited by 52
Arastehfar, A. A., Daneshnia, F., Kord, M., Roudbary, M., Zarrinfar, H., Fang, W., Hashemi, S. J., Najafzadeh, M. J., Khodavaisy, S., Pan, W., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00021 · Cited by 51
Metadata
- Authors
- Chowdhary, A., Sharma, C., & Meis, J. F.
- Affiliations
- University of Delhi (IN)
- Radboud University Medical Center (NL)
- Corresponding author
- Chowdhary, Anuradha
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-05-18
- Volume
- 13
- Issue
- 5
- Pages
- e1006290
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC5436850
- OpenAlex
- W2615277755
- Semantic Scholar
- d65d18115c1babaac00bdb7ec6bf65d6c629eb32
- Cited by
- 750
- References
- 29
- Citations by year
- 2026: 65 · 2025: 78 · 2024: 73 · 2023: 82 · 2022: 64 · 2021: 95 · 2020: 94 · 2019: 84 · 2018: 83 · 2017: 29
- FWCI
- 12.10
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Funders
- University Grants Commission
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- Candida auris, multidrug resistance, nosocomial infections, candidemia, invasive candidiasis, azole resistance, fluconazole resistance, echinocandin resistance, amphotericin B resistance, nosocomial transmission, non-albicans Candida, emerging fungal pathogens
- MeSH terms
- Animals, Candida, Candidiasis, Cross Infection, Humans, Iatrogenic Disease, Drug Resistance, Multiple, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
